1. Gu J, Zhao Y, Wang X, Jiang J, Tian J, Yang K. Registration quality assessment of acupuncture clinical trials. PLoS ONE. 2013;8(3):e59506, PMID:
10.1371/journal.pone.0059506.
2. Birch S. Clinical research on acupuncture: Part 2. Controlled clinical trials, an overview of their methods. J Altern Complement Med. 2004;10(3):481–98.
4. Kim JE, Kang KW, Kim TH, et al. A systematic review and meta-analysis of acupuncture trials in republic of Korea that used sham acupuncture as a control group the acupuncture. The Acupuncture. 2011;28(6):1–17.
5. Jang JY, Kim SJ, Kim NS, Nam SS, Kim YS. Review and analysis of sham acupuncture in acupuncture clinical trials. The Acupuncture. 2011;28(5):29–38.
6. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332, PMID:
10.1136/bmj.c332.
7. MacPherson H, Altman DG, Hammerschlag R, et al. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture(STRICTA): extending the CONSORT statement. PLoS Med. 2010;7(6):e1000261, PMID:
10.1371/journal.pmed.1000261.
8. Gagnier JJ, Boon H, Rochon P, et al. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med. 2006;144(5):364–7.
9. Lee HS, Cha SJ, Park HJ, Seo JC, Park JB, Lee HJ. Revised STandards for Reporting Intervetions in Clinical Trials of Acupuncture(STRICTA): extension the CONSORT statement. Korean Journal of Acupuncture. 2010;27(3):1–23.
10. Kim WY, Lee SD, Lim BM, Kim KS. The assessment of appropriatesness of acupuncture methodology based on STRICTA recommendations. The Acupuncture. 2007;24(5):151–70.
13. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta analyses. Lancet. 1999;354(9193):1896–900.
14. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials. 1996;17(1):1–12.
15. Kim YY, Yoo JH, Lee SK, Lee SW. Quality assessment of randomized controlled trials using herbal remedies in Korea. Korean J Oriental Physiology & Pathology. 2007;25(5):927–33.
16. World Health Organization Regional Office for the Western Pacific. Guideline for clinical research on acupuncture. WHO Regional Publications. Western Pacific Series No. 15. 1995:
17. Kim KS, Yoon JH, Kim KH, Jang JH, Lee SD. Guideline for clinical reasearch on acupuncture. The Acupuncture. 2003;20(5):1–27.
18. MacPherson H, Hammerschlag R, Lewith GT, Schnyer RN. Acupuncture Research. Seoul: Elsevier Korea. 2009:
19. Lee SD. An assessment of statistical validity of articles published in the Journal of Korean Acupuncture & Moxibusition Society: from 1984 to 2002. The Acupuncture. 2004;21(1):176–88.
20. Kwon YK. Development of Korean medicine clinical study guideline. Health Industry Technology Trend. 2006;Summer;128–34.
22. Hammerschlag R. Methodological and ethical issues in clinical trials of acupuncture. J Altern Complement Med. 1998;4(2):159–71.
23. White AR, Filshie J, Cummings TM. International acupuncture research forum. Clinical trials of acupuncture: consensus recommendations for optimal treatment, sham controls and blinding. Complement Ther Med. 2001;9(4):237–45.
24. Sherman KJ, Cherkin DC. Challenges of acupuncture research: study design considerations. Clin Acupunct Orient Med. 2002;3(4):200–6.
25. Gu J, Wang Q, Wang X, et al. Assessment of registration information on methodological design of acupuncture RCTs: a review of 453 registration records retrieved from WHO international clinical trials registry platform. Evid Based Complement Alternat Med. 2014;1–8. PMID:
10.1155/2014/614850.
26. Korea Food and Drug Administration Herbal Medicine Policy Division. Evaluation guideline of herbal medicine clinical trial: antitussive expectorant medicine. Korea Food and Drug Administration. Seoul. 2007;6.
27. Jung HJ, Park JE, Choi SM. Current status of institutional review boards and approvals of clinical research in oriental medical hospitals in Korea: a survey. J Korean Oriental Med. 2010;31(1):122–9.
28. Korea Food and Drug Administration Biopharmaceutical Policy Division. Guideline for biopharmaceutical clinical trial protocol writing: frequently, commonly indicated statistic improvoment point. Korea Food and Drug Administration Biopharmaceutical Policy Division. Seoul. 2013;12.
29. Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for tension-type headache. Cochrane Database Syst Rev. 2009;(1):CD007587, PMID:
10.1002/14651858.CD007587.
30. Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev. 2009;(1):CD001218, PMID:
10.1002/14651858.CD001218.pub2.
31. Hopwood V, Lewith G. Acupuncture trials and methodological considerations. Clin Acupunct Orient Med. 2003;3(4):192–9.
32. Elizabeth AB, Robert JA. Institutional review board: management and function. 1st edition. Seoul: GCO Science. 2011:353–61.
33. Linde K, Dincer F. How informed is consent in sham-controlled trials of acupuncture? J Altern Complement Med. 2004;10(2):379–85. PMID:
10.1089/107555304323062374.